“…Thus, this ruthenium(II)-arene scaffold pro-vides an interesting template for the development of various compounds, with diversities in stability, lipophilicity, solubility and accessibility to modulate synthetic routes. [10][11][12] Herein, the advantages of substituted amino acid ligands which are reported to be fluorescent in nature have been combined with ruthenium(II)-arene scaffolds to determine their activity and effect on anion sensing and bio-imaging studies. 4 In our continuous effort to develop ruthenium based anticancer compounds, [13][14][15] in this work, substituted amino acid ligands [HL1-HL4; HL1 = (2-cyanophenyl) glycine, HL2 = (5-chloro-2-cyanophenyl) glycine, HL3 = (4-chloro-2-cyanophenyl)glycine, and HL4 = (2-cyano-3-fluorophenyl)glycine] have been used to form ruthenium-arene complexes.…”